Get your patients started on AJOVY. Begin here

Frequently asked questions

AJOVY has a long half-life of 31 days

This information should not be construed to imply any difference in safety, efficacy, or other clinical outcome.

View the safety profile of AJOVY.

AJOVY is a fully humanized (IgG2Δa) monoclonal antibody that selectively targets the CGRP ligand1,2


CGRP ligand binding2

The mechanism of action for AJOVY involves exclusive binding of the CGRP


Off-site binding2

AJOVY does not exhibit off-site binding of related calcitonin family members

Learn more about dosing just 4 times a year